UnitedHealth Charged Cancer Patients 5000%, Bombshell FTC Report Claims
The FTC report found that from 2017 to 2022, three PBMs—UnitedHealth Group's Optum, CVS Health's CVS Caremark and Cigna's ...
Medscape16d
Abiraterone Acetate: A Promising Drug for the Treatment of Castration-resistant Prostate Cancer
Abiraterone acetate (CB7630), a pregnenolone analog, is an orally administered small molecule that irreversibly inhibits a rate-limiting enzyme in androgen biosysnthesis, CYP17, and blocks the ...
Targeted Oncology27d
Cusnir Explores Impact of ARANOTE Data on ARPI Plus ADT Use in mHSPC
There are warnings on all of them. They still have the warnings… [with abiraterone (Zytiga)]. I have been decreasing the prednisone even more. I even remember one of the earlier studies that used 4 mg ...
pharmaphorum1y
J&J claims first approval for PARP combo Akeega
In December, AZ and Merck claimed EU approval for the combination of Lynparza with Zytiga, allowing the regimen to be used without the need to test for mutation status. Akeega’s approval is ...
onmanorama4y
This breakthrough discovery can transform prostate cancer treatment
Despite Zytiga being the leading formulation to treat prostate cancer ... The new formulation uses very high levels of abiraterone acetate dissolved within a specific oil and encapsulated within ...
pharmaphorum7y
US court invalidates key patent on J&J's Zytiga
US generic competition for Johnson & Johnson’s (J&J) Zytiga (abiraterone) prostate cancer drug has moved a step closer after a court invalidated a key patent. J&J has said it will appeal against ...